Ziad Younes
- Hepatology top 1%
- Hepatitis C virus research 28
- Liver Diseases and Immunity 8
- Liver Disease and Transplantation 6
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 24
- Hepatitis B Virus Studies 8
- Gastroenterology top 5%
- Infectious Diseases top 10%
-
- Inflammatory Bowel Disease 11
-
- Systemic Lupus Erythematosus Research 8
-
- Eosinophilic Esophagitis 7
- Co-authors
- Stephen A. HarrisonDavid A. JohnsonPaul Y. KwoArun J. SanyalWilliam J. SandbornDavid BernsteinStefan SchreiberGeert D’Haens
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Ziad Younes
65 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Hepatology 882
- Epidemiology 1.3k
- Gastroenterology 76
- Endocrinology, Diabetes and Metabolism 228
- Infectious Diseases 199
Countries citing papers authored by Ziad Younes
This map shows the geographic impact of Ziad Younes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziad Younes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziad Younes more than expected).
Fields of papers citing papers by Ziad Younes
This network shows the impact of papers produced by Ziad Younes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziad Younes. The network helps show where Ziad Younes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ziad Younes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 16 | |
| 2 | 2021 | 18 | |
| 3 | Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitisbreakdown → | 2020 | 218 |
| 4 | 2020 | 5 | |
| 5 | 2020 | 64 | |
| 6 | 2017 | 1 | |
| 7 | Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study | 2016 | 5 |
| 8 | 2015 | 110 | |
| 9 | 2014 | 21 | |
| 10 | 2013 | 10 | |
| 11 | 2011 | 133 | |
| 12 | 2001 | 22 | |
| 13 | 2000 | 3 | |
| 14 | 2000 | 19 | |
| 15 | 1999 | 68 | |
| 16 | 1999 | 2 | |
| 17 | 1999 | 21 | |
| 18 | 1999 | 12 | |
| 19 | 1998 | 4 | |
| 20 | 1997 | 2 |
About Ziad Younes
Ziad Younes is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 67 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (28 papers), Liver Disease Diagnosis and Treatment (24 papers), Inflammatory Bowel Disease (11 papers), Liver Diseases and Immunity (8 papers), Hepatitis B Virus Studies (8 papers), Systemic Lupus Erythematosus Research (8 papers), Eosinophilic Esophagitis (7 papers) and Liver Disease and Transplantation (6 papers). The work is most often cited by research in Hepatology (882 citations), Epidemiology (1.3k citations) and Gastroenterology (76 citations). Ziad Younes has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Stephen A. Harrison, David A. Johnson, Paul Y. Kwo, Arun J. Sanyal, William J. Sandborn, David Bernstein, Stefan Schreiber, Geert D’Haens, Norman Gitlin and Ralph Bloomfield. Their work appears in journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.